Literature DB >> 2182792

The role of inflammation in experimental cerebral vasospasm.

J W Peterson1, B D Kwun, J D Hackett, N T Zervas.   

Abstract

The short-term (less than or equal to 72-hour) cerebral vascular reaction to subarachnoid injectates of various specific blood components was determined by angiography in a canine model of cerebral vasospasm. Cell-free subarachnoid clots of autologous plasma in the basal cistern were found to produce no significant reaction of the basilar artery, while whole-blood clots induced a small (15%) chronic constriction after 24 hours. Because the plasma clots were not well retained in the basal cistern, however, small beads (dextran or latex) were added to stabilize them. Injection of beads and plasma led to moderate-to-severe chronic vasoconstriction (35% to 40%) with rapid onset. Control experiments demonstrated that these foreign bodies (beads) alone induced this vascular reaction. Histological examination showed that severe inflammation followed the introduction of subarachnoid beads. The experiments demonstrate that inflammation alone, in the absence of other processes associated with subarachnoid hemorrhage, may induce persistent and severe cerebroarterial constriction and raises the possibility that inflammation in response to subarachnoid blood may play a role in clinical vasospasm.

Entities:  

Mesh:

Year:  1990        PMID: 2182792     DOI: 10.3171/jns.1990.72.5.0767

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  15 in total

Review 1.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

Review 2.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

Review 3.  Management of cerebral vasospasm.

Authors:  R Loch Macdonald
Journal:  Neurosurg Rev       Date:  2006-02-24       Impact factor: 3.042

4.  Endovascular treatment using low-power ultraviolet laser for delayed vasospasm in the rabbit carotid artery model.

Authors:  Kanji Nakai; Yuji Numaguchi; Thomas H Foster; Katsuji Shima; Makoto Kikuchi
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

5.  Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.

Authors:  Diego Castanares-Zapatero; Philippe Hantson
Journal:  Ann Intensive Care       Date:  2011-05-24       Impact factor: 6.925

Review 6.  The importance of early brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Jack Hou; Ryszard M Pluta; John H Zhang
Journal:  Prog Neurobiol       Date:  2012-03-10       Impact factor: 11.685

7.  Computer assisted quantification of vasospasm on angiograms.

Authors:  M K Baykaner; E Ilgit; I S Keskil; M Altin; S Aykol; N Ceviker
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  Morphometric and ultrastructural analysis of the effect of bromocriptine and cyclosporine on the vasospastic femoral artery of rats.

Authors:  Mehmet Tokmak; Kahan Başocak; Hüseyin Canaz; Gökhan Canaz; Celal İplikçioğlu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  Gene therapy for cerebral vascular disease: update 2003.

Authors:  Kazunori Toyoda; Yi Chu; Donald D Heistad
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway.

Authors:  Aida Maddahi; Gro Klitgaard Povlsen; Lars Edvinsson
Journal:  J Neuroinflammation       Date:  2012-12-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.